Endocrine System

Hormone Replacement Therapy Practice Questions

18 free Hormone Replacement Therapy practice questions for the NCLEX Exam, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Hormone Replacement Therapy questions

18 questions
  1. Q1. Why is progestogen included in combined estrogen and progestogen therapy for a post-menopausal woman with an intact uterus?
  2. Q2. What is the most accurate statement regarding the timing of starting menopausal hormone therapy (MHT)?
  3. Q3. What is not expected to be assessed by the provider prior to initiating hormone replacement therapy?
  4. Q4. What hormone replacement regimen does a woman with a hysterectomy only need if symptomatic for menopause?
  5. Q5. Which route of estrogen administration is preferred for a woman with increased risk of venous thromboembolism?
  6. Q6. What is the next best action if a 52-year-old woman on hormone replacement reports new-onset irregular vaginal bleeding?
  7. Q7. What do current guidelines recommend regarding hormone therapy for a woman seeking it primarily for osteoporosis prevention?
  8. Q8. What is the recommended approach for treating central hypothyroidism (due to pituitary deficiency)?
  9. Q9. What options are available if a patient has contraindications to hormone replacement therapy and does not want to proceed with it?
  10. Q10. What is the correct guidance regarding the duration of hormone therapy use for a woman on estrogen therapy?
  11. Q11. What is the most appropriate laboratory monitoring for a woman on systemic hormone replacement therapy?
  12. Q12. In a woman on estrogen replacement who reports headache, visual changes, and elevated blood pressure, what does this indicate?
  13. Q13. What is an accurate statement regarding vaginal estrogen for genitourinary syndrome of menopause?
  14. Q14. What would be a contraindication to systemic hormone replacement therapy?
  15. Q15. How does smoking affect the risk of hormone therapy in women?
  16. Q16. In a woman on hormone replacement reporting thigh pain and swelling, what could this indicate?
  17. Q17. For a woman continuing hormone therapy at age 65 with persistent moderate symptoms, what is the appropriate action?
  18. Q18. What monitoring is emphasized in hormone replacement therapy for transgender care?